Label-free machine learning detects a multi-cancer signal in a noninvasive urine and plasma metabolite panel: a case-control study.
We assessed how well a four-metabolite panel separates cancer cases from controls across eight cancer types, whether this separation is detectable without outcome labels, and how performance translates to realistic prevalence. We evaluated survival association and predictive values across prevalence.
We assessed how well a four-metabolite panel separates cancer cases from controls across eight cancer types, whether this separation is detectable without outcome labels, and how performance translates to realistic prevalence. We evaluated survival association and predictive values across prevalence.
What the study was
- Study design
- Cohort study
- Population
- n=4105
- Sample size
- n=4105
- Category
- Other
- Maturity
- Exploratory
- Journal
- medRxiv : the preprint server for health sciences
Why it surfaced
⚪ PROMISING_PRELIMINARY — Promising but preliminary; Watchlist: Early cancer detection (liquid biopsy, ctDNA, cfDNA); Design: Cohort study; species: human
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.